Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-frequency chest wall oscillation in ALS: an exploratory randomized, controlled trial.

D J Lange1, N Lechtzin, C Davey

  • 1Department of Neurology, Mt. Sinai School of Medicine, One Gustave L. Levy Place, Box 1052, New York, NY 10029, USA. dale.lange@mssm.edu

Neurology
|September 27, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases.

Experimental dermatology·2004
Same author

Pressure simulation of orthodontic force in osteoblasts: a pilot study.

Orthodontics & craniofacial research·2004
Same author

Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.

Experimental dermatology·2004
Same author

Upregulation of MCAM in primary bronchial epithelial cells from patients with COPD.

The European respiratory journal·2003
Same author

Centrality dependence of charged-hadron transverse-momentum spectra in d+Au collisions at sqrt[s(NN)]=200 GeV.

Physical review letters·2003
Same author

Living well but poorly.

The American journal of nursing·2002

High-frequency chest wall oscillation (HFCWO) improved breathlessness and reduced fatigue in ALS patients. This therapy was well-tolerated and showed a trend toward preserving lung function over 12 weeks.

Area of Science:

  • Pulmonary Medicine
  • Neurology
  • Respiratory Therapy

Background:

  • Amyotrophic Lateral Sclerosis (ALS) progressively impairs respiratory function, leading to significant morbidity.
  • Effective management strategies are crucial for improving quality of life in ALS patients.

Purpose of the Study:

  • To evaluate the impact of high-frequency chest wall oscillation (HFCWO) on respiratory function in patients with ALS.
  • To assess changes in breathlessness, cough, and lung function parameters.

Main Methods:

  • A 12-week randomized, controlled trial involving patients with probable or definite ALS.
  • Participants had specific scores on the ALS Functional Rating Scale respiratory subscale and forced vital capacity (FVC).
  • Comparison between an HFCWO group and an untreated control group.

Related Experiment Videos

Main Results:

  • HFCWO users reported reduced breathlessness and increased nighttime coughing compared to baseline.
  • A subgroup analysis indicated that HFCWO patients maintained FVC, unlike untreated patients.
  • HFCWO demonstrated a trend toward slowing FVC decline and reducing fatigue and breathlessness in patients with moderate respiratory impairment.

Conclusions:

  • High-frequency chest wall oscillation (HFCWO) is well-tolerated and beneficial for a majority of ALS patients.
  • HFCWO effectively decreases breathlessness and fatigue in individuals with impaired respiratory function.
  • The therapy shows potential in mitigating the decline of forced vital capacity in ALS.